Prestige Consumer Healthcare (NYSE:PBH) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Prestige Consumer Healthcare (NYSE:PBHGet Free Report) issued its earnings results on Thursday. The company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.02, Briefing.com reports. The firm had revenue of $282.74 million for the quarter, compared to the consensus estimate of $280.25 million. Prestige Consumer Healthcare had a positive return on equity of 14.09% and a negative net margin of 7.11%. The company’s revenue was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.04 earnings per share. Prestige Consumer Healthcare updated its FY 2024 guidance to 4.330-4.330 EPS.

Prestige Consumer Healthcare Trading Down 0.2 %

PBH traded down $0.13 during midday trading on Friday, hitting $68.67. 291,307 shares of the company traded hands, compared to its average volume of 244,051. The business has a 50 day simple moving average of $60.94 and a two-hundred day simple moving average of $60.23. Prestige Consumer Healthcare has a 52-week low of $55.96 and a 52-week high of $69.29. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.75 and a current ratio of 3.09.

Wall Street Analyst Weigh In

Several equities research analysts have commented on PBH shares. BMO Capital Markets lowered their price objective on Prestige Consumer Healthcare from $124.00 to $117.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 15th. StockNews.com raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, Royal Bank of Canada cut their price target on Prestige Consumer Healthcare from $110.00 to $103.00 and set a “sector perform” rating for the company in a research note on Wednesday, November 15th. One equities research analyst has rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, Prestige Consumer Healthcare currently has an average rating of “Moderate Buy” and an average price target of $97.00.

View Our Latest Report on Prestige Consumer Healthcare

Institutional Trading of Prestige Consumer Healthcare

Institutional investors and hedge funds have recently modified their holdings of the stock. Altshuler Shaham Ltd purchased a new stake in Prestige Consumer Healthcare during the 4th quarter worth approximately $27,000. Natixis acquired a new stake in shares of Prestige Consumer Healthcare in the fourth quarter worth approximately $36,000. International Assets Investment Management LLC increased its position in shares of Prestige Consumer Healthcare by 1,900.0% during the fourth quarter. International Assets Investment Management LLC now owns 980 shares of the company’s stock worth $60,000 after purchasing an additional 931 shares in the last quarter. Rockefeller Capital Management L.P. raised its stake in Prestige Consumer Healthcare by 86.8% in the 4th quarter. Rockefeller Capital Management L.P. now owns 1,128 shares of the company’s stock valued at $70,000 after purchasing an additional 524 shares during the last quarter. Finally, Tower Research Capital LLC TRC lifted its holdings in Prestige Consumer Healthcare by 131.0% in the 3rd quarter. Tower Research Capital LLC TRC now owns 2,559 shares of the company’s stock valued at $146,000 after purchasing an additional 1,451 shares in the last quarter. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Company Profile

(Get Free Report)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Featured Articles

Earnings History for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.